Alector, Inc. reports results for the quarter ended September 30 - Earnings Summary
Alector, Inc. reports results for the quarter ended September 30 - Earnings Summary
Alector, Inc. ALEC.OQ reported quarterly adjusted earnings of $1.11 per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -34 cents. The mean expectation of seven analysts for the quarter was for a loss of 23 cents per share. Wall Street expected results to range from -24 cents to -22 cents per share.
Revenue rose 4,895.9% to $162.87 million from a year ago; analysts expected $2.68 million.
Alector, Inc.'s reported EPS for the quarter was $1.11.
The company reported quarterly net income of $124.66 million.
Alector, Inc. shares had risen by 23.2% this quarter and gained 46.2% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 0.4% in the last three months.
In the last 30 days, one analyst negatively revised an earnings estimate
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy," 2 "hold" and 2 "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is "buy."
Wall Street's median 12-month price target for Alector, Inc. is $4.50, about 49.3% above its last closing price of $2.28
This summary was machine generated from LSEG data November 5 at 11:26 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Sep. 30 2026 | -0.23 | 1.11 | Beat |
Jun. 30 2026 | -0.23 | -0.21 | Beat |
Mar. 31 2026 | -0.34 | -0.21 | Beat |
Dec. 31 2025 | -0.38 | -0.34 | Beat |